ALS Management

Management criteria checks 2/4

ALS' CEO is Malcolm Deane, appointed in Mar 2023, has a tenure of 1.08 years. total yearly compensation is A$1.34M, comprised of 5.5% salary and 94.5% bonuses, including company stock and options. directly owns 0.003% of the company’s shares, worth €124.06K. The average tenure of the management team and the board of directors is 1.1 years and 4.4 years respectively.

Key information

Malcolm Deane

Chief executive officer

AU$1.3m

Total compensation

CEO salary percentage	5.5%
CEO tenure	1.1yrs
CEO ownership	0.003%
Management average tenure	1.1yrs
Board average tenure	4.4yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Malcolm Deane's remuneration changed compared to ALS's earnings?
Date	Total Compensation	Salary	Company Earnings
Sep 30 2023	n/a	n/a	AU$264m
Jun 30 2023	n/a	n/a	AU$270m
Mar 31 2023	AU$1m	AU$73k	AU$275m

Compensation vs Market: Malcolm's total compensation ($USD872.69K) is below average for companies of similar size in the German market ($USD2.56M).

Compensation vs Earnings: Insufficient data to compare Malcolm's compensation with company performance.

CEO

Malcolm Deane (39 yo)

1.1yrs

Tenure

AU$1,335,563

Compensation

Mr. Malcolm Deane, Master of Laws, Juris Doctor, serves as Chief Executive Officer of ALS Limited since May 08, 2023 and had been its Acting Chief Executive Officer since March 06, 2023 until May 08, 2023...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Malcolm Deane	CEO, MD & Director	1.1yrs	AU$1.34m	0.0032% A$ 124.1k
Michael Pearson	General Counsel & Company Secretary	6.3yrs	no data	no data
Michael Burcham	Chief Risk Officer	no data	no data	no data
Heike Truol	Chief Strategy Officer	less than a year	no data	no data
Greg Affleck	Group Financial Controller	no data	no data	no data

1.1yrs

Average Tenure

Experienced Management: CP4's management team is not considered experienced ( 1.1 years average tenure), which suggests a new team.

Board Members

Name	Position	Tenure	Compensation	Ownership
Malcolm Deane	CEO, MD & Director	1.1yrs	AU$1.34m	0.0032% A$ 124.1k
John Mulcahy	Independent Non-Executive Director	12.2yrs	AU$205.66k	0.016% A$ 630.7k
Nigel Garrard	Independent Non-Executive Director	less than a year	no data	0.0027% A$ 102.8k
Bruce Phillips	Independent Chairman	8.7yrs	AU$374.50k	0.023% A$ 879.6k
Tonianne Dwyer	Independent Non-Executive Director	7.8yrs	AU$215.66k	0.0056% A$ 216.8k
Leslie Desjardins	Independent Non-Executive Director	4.4yrs	AU$215.34k	0.0029% A$ 112.5k
Erica Mann	Independent Non-Executive Director	less than a year	no data	no data
Peter Possemiers	Independent Non-Executive Director	1.4yrs	AU$81.21k	0.0027% A$ 105.5k
Siddhartha Kadia	Independent Non-Executive Director	5.3yrs	AU$210.22k	0.0019% A$ 75.0k

4.4yrs

Average Tenure

62yo

Average Age

Experienced Board: CP4's board of directors are considered experienced (4.4 years average tenure).

ALS Management

Management criteria checks 2/4

Key information

Recent management updates

ALS Limited, Annual General Meeting, Jul 31, 2024

ALS Limited Appoints Stuart Hutton as Chief Financial Officer, Effective 1 February 2024

ALS Limited Announces Stepdown of Luis Damasceno as Chief Financial Officer, Effective 19 January 2024

ALS Limited Appoints Heike Truöl as Chief Strategy Officer

Independent Chairman recently bought €364k worth of stock

ALS Limited Announces Board Changes

Recent updates

ALS Limited (ASX:ALQ) agreed to acquire Wessling Holding Gmbh & Co.Kg.

Now 20% undervalued after recent price drop

Now 20% undervalued

ALS Limited, Annual General Meeting, Jul 31, 2024

ALS Limited Appoints Stuart Hutton as Chief Financial Officer, Effective 1 February 2024

Investor sentiment improves as stock rises 19%

ALS Limited Announces Stepdown of Luis Damasceno as Chief Financial Officer, Effective 19 January 2024

ALS Limited Appoints Heike Truöl as Chief Strategy Officer

ALS Limited to Report Fiscal Year 2024 Results on May 21, 2024

Independent Chairman recently bought €364k worth of stock

ALS Limited Announces Board Changes

Upcoming dividend of AU$0.19 per share at 3.4% yield

ALS Limited Declares Final Dividend for the Fiscal Year 2023, Payable on 6 July 2023

Full year 2023 earnings released: EPS: AU$0.57 (vs AU$0.39 in FY 2022)

ALS Limited Appoints Malcolm Deane as Managing Director

Insufficient new directors

Upcoming dividend of AU$0.20 per share

First half 2023 earnings released: EPS: AU$0.30 (vs AU$0.15 in 1H 2022)

ALS Limited Declares an Unfranked Interim Dividend for the First Half of Fiscal Year 2023, Payable on 16 December 2022

ALS Limited Appoints Peter Possemiers as an Independent Non-Executive Director Effective 1 November 2022

ALS Limited Declares Final Dividend

ALS Limited (ASX:ALQ) announces an Equity Buyback for 9,000,000 shares, representing 1.86% for AUD 100 million.

ALS Limited to Report Fiscal Year 2023 Results on May 24, 2023

ALS Limited (ASX:ALQ) made an non-binding indicative offer to acquire HRL Holdings Limited (ASX:HRL) for AUD 79 million.

ALS Limited (ASX:ALQ) made an non-binding indicative offer to acquire HRL Holdings Limited (ASX:HRL) for AUD 79 million.

Independent Non-Executive Director recently bought €59k worth of stock

Independent Non-Executive Director recently bought €59k worth of stock

Upcoming dividend of AU$0.17 per share

Full year 2022 earnings released: EPS: AU$0.40 (vs AU$0.36 in FY 2021)

ALS Limited Declares Dividend for the Period Ended March 31, 2022, Payable on July 4, 2022

ALS Limited Declares Dividend for the Period Ended March 31, 2022, Payable on July 4, 2022

ALS Limited to Report First Half, 2023 Results on Nov 14, 2022

Insufficient new directors

Investor sentiment improved over the past week

Insufficient new directors

ALS Limited (ASX:ALQ) agreed to acquire MinAnalytical Laboratory Services Pty Ltd. from Perenti Global Limited (ASX:PRN) for AUD 39 million.

Upcoming dividend of AU$0.16 per share

First half 2022 earnings released: EPS AU$0.15 (vs AU$0.14 in 1H 2021)

Independent Non-Executive Director recently bought €73k worth of stock

Investor sentiment improved over the past week

Upcoming dividend of AU$0.15 per share

Full year 2021 earnings released: EPS AU$0.36 (vs AU$0.16 in FY 2020)

ALS Limited Declares Final Dividend, payable on July 5, 2021

ALS Limited (ASX:ALQ) entered in an agreement to acquire Investiga.

New 90-day high: €6.90

New 90-day high: €6.45

ALS Limited to Report Fiscal Year 2021 Final Results on Jun 23, 2021

First half 2021 earnings released: EPS AU$0.15

ALS Limited, Annual General Meeting, Jul 28, 2021

Revenue misses expectations

ALS Limited to Report Fiscal Year 2021 Results on May 26, 2021

New 90-day high: €6.00

New 90-day high: €5.80

New 90-day high: €5.75

New 90-day high - €5.50

New 90-day high - €5.40

New 90-day high - €4.58

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Board Members

Average Tenure

Average Age